• Low-Dose Cadmium, STAT3, and Lymphangiogenesis

  2026-08-16

  The reference study identifies STAT3 activation as a signaling link between low-dose cadmium exposure and enhanced lymphatic vessel growth after corneal injury. Its combination of an in vivo alkali-burn model, lymphatic endothelial cell assays, pathway profiling, and STAT3 inhibition supports a cadmium–STAT3–VEGFR3 mechanism while also revealing dose-dependent effects.

• Brassinolide: Mechanism, Evidence, and Workflows

  2026-08-15

  Brassinolide, also called 24-Epibrassinolide, is a plant steroid regulator with documented roles in plant development and research-reported effects in PC-3 prostate cancer cells and diabetic rat models. The evidence supports controlled use in plant bioassays, apoptosis studies, and metabolic research, but does not establish clinical efficacy.

• PDK4 Inhibitors: Mechanism, Models, and Translational Value

  2026-08-14

  The reference study used anthraquinone hit optimization to discover allosteric pyruvate dehydrogenase kinase 4 inhibitors, identifying compound 8c as a lead with biochemical, metabolic, allergic-disease, and anticancer activity. Its integrated potency, stability, pharmacokinetic, animal-model, cellular, and docking data provide a useful framework for assessing whether PDK4 inhibition can support broader metabolic-disease drug development.

• Zolmitriptan: From 5-HT1B Signaling to Translational Assays

  2026-08-14

  Zolmitriptan provides a defined pharmacological entry point for migraine and cluster headache research. This thought-leadership guide connects 5-HT receptor assay design with an evidence-bounded framework for exploring lysosomal biology without overstating an unproven cross-domain mechanism.

• AIBP–LRP2 Control of Collateral Circulation

  2026-08-13

  Zhu et al. identify an AIBP–LRP2–HDL–miR-223 pathway that restrains CXCR4-positive, stemlike capillary endothelial cells during collateral vessel formation. The study links ischemia-induced lipid handling to a two-phase vascular remodeling process and suggests that disrupting this axis may improve revascularization in peripheral artery disease.

• Formononetin Protects Neurons During Oxaliplatin Therapy

  2026-08-13

  The reference study identifies formononetin as a neuroprotective isoflavone that reduces oxaliplatin-induced oxidative stress and neuronal apoptosis through the Nrf2/HO-1 pathway. Its most important translational finding is that neuronal protection was retained without weakening oxaliplatin or paclitaxel anticancer activity in the tested cancer-cell models, although protection against paclitaxel-related neurite damage was limited.

• Clozapine: A Translational Assay Framework

  2026-08-12

  Clozapine is an atypical antipsychotic medication with a distinctive receptor and ERK1/2 signaling profile. This article develops a practical, cross-scale assay framework linking pharmacology, prefrontal circuitry, magnetic neuromodulation, and hepatotoxicity studies.

• Adefovir: From HBV Polymerase to Renal Risk

  2026-08-12

  Adefovir and GS-0393 connect HBV polymerase inhibition with OAT1-mediated renal handling. This evidence-led guide translates mechanism, exposure, and adefovir-associated phosphate wasting into more discriminating research assay decisions.

• FGFR1 as a Druggable Target in Schizophrenia

  2026-08-11

  A 2025 Molecular Neurobiology study integrated genetic causal-inference methods, colocalization, phenome-wide screening, drug prediction, docking, and single-cell analysis to identify six druggable genes associated with schizophrenia. FGFR1 emerged as the leading candidate, but the findings remain target-discovery evidence rather than proof of clinical efficacy or a validated schizophrenia treatment.

• Deep Learning Maps Cardiotoxicity in iPSC-CMs

  2026-08-11

  Grafton et al. developed a scalable phenotypic screen that combines high-content imaging of induced pluripotent stem cell-derived cardiomyocytes with deep learning to identify cardiotoxic patterns. The approach detected liabilities across mechanistically diverse compounds and provides a practical framework for earlier toxicity triage during discovery and lead optimization.

• Thiothixene: Efferocytosis Workflow and Research Outlook

  2026-08-10

  Thiothixene combines established dopamine and serotonin receptor pharmacology with a practical research use-case in macrophage efferocytosis assays. This guide translates that dual profile into an executable cell workflow, controls, troubleshooting logic, and a cautious bridge to emerging schizophrenia target-discovery research.

• Homoharringtonine and SARS-CoV-2: Study Analysis

  2026-08-09

  The reference study evaluates Homoharringtonine as a broad coronavirus replication inhibitor and combines in vitro, mouse, and early human evidence. Its central innovation is a proposed upper-respiratory-tract intervention based on protein-elongation inhibition, although the small, uncontrolled clinical cohorts require cautious interpretation and further validation.

• Uridine, Trisodium Salt for RNA Workflows

  2026-08-08

  Uridine, Trisodium Salt supports cell-based RNA metabolism studies and vascular assays while helping researchers control reagent solubility and nucleotide handling. Its most useful role in PRINT workflows is as a carefully characterized cellular input and assay variable—not as a direct substitute for UTP in in vitro transcription.

• Cucurbitacin I: A Causal Perturbation Playbook

  2026-08-07

  Cucurbitacin I (JSI-124) is more than a STAT3 pathway inhibitor: it is a useful causal probe when molecular, phenotypic, and multicellular assay layers are aligned. This article connects its oncology applications with design principles from human SAN-plexus assembloids while clearly separating methodological insight from unsupported cardiac claims.

• Brassinolide: Precision Tool for Plant Growth and Apoptosis

  2026-08-07

  Brassinolide (24-Epibrassinolide) stands out as a dual-function molecule, enabling high-performance plant growth modulation and targeted apoptosis studies in oncology and metabolic disease models. This guide delivers expert protocol enhancements, troubleshooting strategies, and actionable insights for maximizing assay reliability with APExBIO’s Brassinolide.

7974 records 8/532 page Previous Next First page 上5页 678910 下5页 Last page